Clinical Trials Browser

Interventional × Adult Solid Tumor × Bevacizumab × Clear all

NCT01332721 2018-12-05

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Phase 1 Completed

38 enrolled 8 charts

Other solid neoplasm

Adult Solid Tumor